Market revenue in 2023 | USD 175.3 million |
Market revenue in 2030 | USD 282.8 million |
Growth rate | 7.1% (CAGR from 2023 to 2030) |
Largest segment | Biorepository services |
Fastest growing segment | Biorepository Services |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Biorepository Services, Archiving Solution Services |
Key market players worldwide | Azenta Inc, Thermo Fisher Scientific Inc, Precision for Medicine, Medpace Holdings Inc, Labcorp Drug Development, ATCC, Q2 Solutions, LabConnect, Charles River Laboratories International Inc |
Biorepository services was the largest segment with a revenue share of 66.34% in 2023. Horizon Databook has segmented the Spain clinical trial biorepository & archiving solutions market based on biorepository services, archiving solution services covering the revenue growth of each sub-segment from 2018 to 2030.
Spain clinical trial biorepository & archiving solutions market is anticipated to witness moderate growth rate over the forecast period. Biobanks and clinical trial biorepository & archiving solutions are still in developing stage in Spain. However, favorable healthcare system in Spain may encourage many major players to enter the market, thereby propelling market growth.
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account